ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in February 2026. Updated February 5.
A roundup of FDA’s actions in February 2026.
FDA Output, February 2026
×
